Eyal Breitbart, Ph.D. joined VBL Therapeutics in 2001. He has extensive experience in cancer and immune-inflammatory research as well as in biochemical, immunological and molecular biology methods. He brings over 20 years of experience in product engineering, process characterization and qualification, large scale manufacturing, product chain supply, data management and computerized system integration. Dr. Breitbart is a professional and experienced manager, in charge of the Company's daily operations, including VBL's manufacturing facility and the full spectrum of aspects related to research and production. Dr. Breitbart earned a doctor of philosophy degree from Bar-Ilan University, Ramat Gan, Israel and completed a post-doctoral fellowship at Tufts University School of Medicine in Boston.